We are live on ! Find out more
SSIA

Spero-Smith Investment Advisers Portfolio holdings

AUM $74.5M
1-Year Est. Return 12.27%
This Fund
S&P 500
This Quarter Est. Return
+6.47%
1 Year Est. Return
+12.27%
3 Year Est. Return
+31.25%
5 Year Est. Return
10 Year Est. Return
AUM
$78.6M
AUM Growth
+$4.67M
Cap. Flow
+$135K
Cap. Flow %
0.17%
Top 10 Hldgs %
44.14%
Holding
46
New
4
Increased
2
Reduced
34
Closed

Top Buys

Rank Stock Value
1
ECL icon
Ecolab
ECL
+$1.39M
2
TGT icon
Target
TGT
+$1.33M
3
UNH icon
UnitedHealth
UNH
+$694K
4
SBUX icon
Starbucks
SBUX
+$219K
5
IBM icon
IBM
IBM
+$16.5K

Top Sells

Rank Stock Value
1
FISV
Fiserv Inc
FISV
+$1.02M
2
MCK icon
McKesson
MCK
+$460K
3
JNJ icon
Johnson & Johnson
JNJ
+$201K
4
DHR icon
Danaher
DHR
+$139K
5
HBAN icon
Huntington Bancshares
HBAN
+$127K

Sector Composition

Rank Sector Weight
1 Technology 21.19%
2 Energy 18.47%
3 Healthcare 18.33%
4 Financials 12.17%
5 Communication Services 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
1
ExxonMobil
XOM
$654B
$11M 13.94%
140,518
-1,228
-0.9% -$98.2K
GOOG icon
2
Alphabet (Google) Class C
GOOG
$4.08T
$3.33M 4.24%
86,460
-3,460
-4% -$124K
MSFT icon
3
Microsoft
MSFT
$2.92T
$2.87M 3.65%
51,674
-939
-2% -$49.4K
WFC icon
4
Wells Fargo
WFC
$257B
$2.78M 3.54%
51,175
-1,734
-3% -$94.2K
ACN icon
5
Accenture
ACN
$107B
$2.65M 3.37%
25,324
-828
-3% -$87.4K
SHW icon
6
Sherwin-Williams
SHW
$84.9B
$2.62M 3.34%
30,291
DHR icon
7
Danaher
DHR
$142B
$2.55M 3.25%
40,831
-2,227
-5% -$139K
HBAN icon
8
Huntington Bancshares
HBAN
$34.3B
$2.33M 2.97%
211,116
-11,355
-5% -$127K
CVS icon
9
CVS Health
CVS
$137B
$2.33M 2.96%
23,804
-489
-2% -$47.9K
INTC icon
10
Intel
INTC
$415B
$2.26M 2.88%
65,660
-1,786
-3% -$60.4K
CELG
11
DELISTED
Celgene Corp
CELG
$2.19M 2.79%
18,305
-660
-3% -$76.4K
FISV
12
Fiserv Inc
FISV
$29.8B
$2.11M 2.68%
46,072
-21,670
-32% -$1.02M
TRV icon
13
Travelers Companies
TRV
$82.2B
$2.09M 2.66%
18,481
-895
-5% -$99.4K
MCK icon
14
McKesson
MCK
$106B
$2.06M 2.62%
10,450
-2,437
-19% -$460K
TMO icon
15
Thermo Fisher Scientific
TMO
$215B
$2.03M 2.58%
14,287
-45
-0.3% -$6K
SRCL
16
DELISTED
Stericycle Inc
SRCL
$2.01M 2.56%
16,698
-609
-4% -$77.6K
VZ icon
17
Verizon
VZ
$201B
$2M 2.54%
43,193
-500
-1% -$22.7K
ANSS
18
DELISTED
Ansys
ANSS
$1.93M 2.45%
20,831
-455
-2% -$42K
NVS icon
19
Novartis
NVS
$301B
$1.86M 2.36%
24,069
-664
-3% -$52.7K
CERN
20
DELISTED
Cerner Corp
CERN
$1.73M 2.2%
28,730
-330
-1% -$20.3K
EMC
21
DELISTED
EMC CORPORATION
EMC
$1.68M 2.14%
65,512
-3,673
-5% -$95.4K
SNI
22
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$1.61M 2.05%
29,182
-1,289
-4% -$72.5K
MET icon
23
MetLife
MET
$62.4B
$1.56M 1.98%
36,272
-2,149
-6% -$94.5K
COP icon
24
ConocoPhillips
COP
$144B
$1.41M 1.79%
30,089
-792
-3% -$41.4K
IBM icon
25
IBM
IBM
$214B
$1.39M 1.77%
10,598
+123
+1% +$16.5K

Similar funds

Spero-Smith Investment Advisers's Q4 2015 Portfolio in Review

As of Q4 2015, Spero-Smith Investment Advisers held 46 positions worth $78.6M, up 6.3% from $73.9M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Spero-Smith Investment Advisers's Q4 2015 filing shows 4 new, 2 increased and 34 reduced positions. Its largest new stake was Ecolab: 11,805 shares worth $1.35M. The largest sale was Fiserv Inc, an estimated $1.02M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Energy and Healthcare.

  • Spero-Smith Investment Advisers's largest Q4 2015 buy was Ecolab: 11,805 shares worth $1.35M.
  • Spero-Smith Investment Advisers added most to IBM in Q4 2015, an estimated $16.5K increase.
  • Spero-Smith Investment Advisers's biggest Q4 2015 reduction was Fiserv Inc, cutting an estimated $1.02M.
  • Spero-Smith Investment Advisers's ten largest holdings make up 44% of its $78.6M portfolio in Q4 2015.
  • Spero-Smith Investment Advisers opened 4 new positions and closed 0 in Q4 2015.
  • Spero-Smith Investment Advisers's portfolio value rose 6.3% quarter-over-quarter to $78.6M.

Based on Spero-Smith Investment Advisers's 13F filing for Q4 2015, filed 8 Feb 2016.